Clinical Trial: Dexamethasone Efficacy in HELLP I Syndrome

Study Status: Not yet recruiting
Recruit Status: Unknown status
Study Type: Interventional




Official Title: Dexamethasone Efficacy in HELLP I Syndrome, a Multicentric, Double-blind, Placebo-controlled, Randomized Clinical Trial

Brief Summary: The purpose of this study is to determine the efficacy of dexamethasone for treatment of HELLP I (hemolysis, elevated liver enzymes and low platelet count) syndrome.